What insurance policy changes affect code K22.711?

There are 3 tracked policy changes affecting code K22.711, including updates from Aetna, Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code K22.711?

Payers that have issued tracked updates for code K22.711 include: Aetna, Blue Cross & Blue Shield of Mississippi.

How do I get notified when code K22.711 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code K22.711. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code K22.711?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

K22.711 Insurance Policy Changes

ICD-10 K22.711 is officially defined as "Barrett's esophagus with high grade dysplasia." code K22.711 is referenced in 3 tracked payer policy changes from Aetna and Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code K22.711 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Aetna · Identified Oct 31, 2026Medium impact
Barrett's Esophagus (CPB 0728, reviewed 2026-10-26)
Aetna's Clinical Policy Bulletin 0728 on Barrett's esophagus (reviewed 2026-10-26) considers radiofrequency ablation medically necessary for members with low-grade dysplasia confirmed by histology from 2 or more endoscopies 3 or more months apart. For members with high-grade dysplasia by biopsy, it considers endoscopic mucosal resection, esophagectomy, fundoplication, photodynamic therapy and radiofrequency ablation medically necessary, and it considers argon plasma coagulation, cryotherapy, laser therapy and several other listed interventions and tests experimental, investigational, or unproven because their effectiveness has not been established.
Aetna · Identified Aug 12, 2026Medium impact
Barrett's Esophagus (CPB 0728, reviewed 2025-11-25)
Aetna considers radiofrequency ablation medically necessary for Barrett's esophagus with low-grade dysplasia confirmed by histology on 2 or more endoscopies performed 3 or more months apart. For Barrett's esophagus with high-grade dysplasia by biopsy, endoscopic mucosal resection, esophagectomy, fundoplication, photodynamic therapy and radiofrequency ablation are considered medically necessary. Argon plasma coagulation, cryotherapy or cryoablation, laser therapy, chemoradiation therapy, gastrectomy, multi-polar electro-coagulation and ultrasonic therapy are considered experimental, investigational or unproven for Barrett's esophagus.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Oncologic Applications of Photodynamic Therapy, Including Barrett Esophagus
Photodynamic therapy may be considered medically necessary for palliative treatment of obstructing esophageal cancer, palliative treatment of obstructing endobronchial lesions, early-stage non-small-cell lung cancer in individuals ineligible for surgery and radiotherapy, high-grade dysplasia in Barrett esophagus, and palliative treatment of unresectable cholangiocarcinoma when used with stenting. Other oncologic applications, including Barrett esophagus without high-grade dysplasia, are investigational. The policy history records a 09/12/2025 description update, with policy guidelines updated regarding focal therapy.

Watch K22.711

Get one email when a payer policy names K22.711, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Barrett's Esophagus (CPB 0728, reviewed 2026-10-26)

Barrett's Esophagus (CPB 0728, reviewed 2025-11-25)

Oncologic Applications of Photodynamic Therapy, Including Barrett Esophagus

What insurance policy changes affect code K22.711?

Which payers have updated policy for code K22.711?

How do I get notified when code K22.711 policy changes?

Why do payers change policies for code K22.711?